In a filing, Ceribell Inc revealed its Director ROBERTSON REBECCA B unloaded Company’s shares for reported $0.2 million on Jun 18 ’25. In the deal valued at $17.85 per share,11,188 shares were sold. As a result of this transaction, ROBERTSON REBECCA B now holds 10,042 shares worth roughly $0.2 million.
Then, ROBERTSON REBECCA B sold 7,445 shares, generating $131,255 in total proceeds. Upon selling the shares at $17.63, the Director now owns 21,230 shares.
Before that, Copp Joshua bought 11,188 shares. Ceribell Inc shares valued at $199,715 were divested by the Former Officer at a price of $17.85 per share.
BTIG Research initiated its Ceribell Inc [CBLL] rating to a Buy in a research note published on June 24, 2025; the price target was $30. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. William Blair began covering CBLL with “an Outperform” recommendation on November 05, 2024. TD Cowen started covering the stock on November 05, 2024. It rated CBLL as “a Buy”.
Price Performance Review of CBLL
On Tuesday, Ceribell Inc [NASDAQ:CBLL] saw its stock jump 6.27% to $19.65. Over the last five days, the stock has gained 14.11%. Nevertheless, the stocks have fallen -24.07% over the past one year.
Levels Of Support And Resistance For CBLL Stock
The 24-hour chart illustrates a support level at 18.78, which if violated will result in even more drops to 17.90. On the upside, there is a resistance level at 20.31. A further resistance level may holdings at 20.96.
How much short interest is there in Ceribell Inc?
A steep rise in short interest was recorded in Ceribell Inc stocks on 2025-05-30, dropping by -0.28 million shares to a total of 1.07 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 1.35 million shares. There was a decline of -26.32%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 05, 2024 when JP Morgan began covering the stock and recommended ‘”an Overweight”‘ rating along with a $32 price target.
